1. Home
  2. CPIX vs CYPH Comparison

CPIX vs CYPH Comparison

Compare CPIX & CYPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cumberland Pharmaceuticals Inc.

CPIX

Cumberland Pharmaceuticals Inc.

HOLD

Current Price

$6.31

Market Cap

73.6M

Sector

Health Care

ML Signal

HOLD

CYPH

Cypherpunk Technologies Inc.

HOLD

Current Price

$0.68

Market Cap

73.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CPIX
CYPH
Founded
1999
2011
Country
United States
United States
Employees
N/A
6
Industry
Biotechnology: Pharmaceutical Preparations
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
73.6M
73.4M
IPO Year
2007
N/A

Fundamental Metrics

Financial Performance
Metric
CPIX
CYPH
Price
$6.31
$0.68
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
42.7K
5.6M
Earning Date
05-05-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
58.70
N/A
EPS
N/A
N/A
Revenue
$42,010,949.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
16.75
N/A
52 Week Low
$1.85
$0.49
52 Week High
$7.21
$3.70

Technical Indicators

Market Signals
Indicator
CPIX
CYPH
Relative Strength Index (RSI) 57.66 44.29
Support Level $5.42 $0.52
Resistance Level $6.61 $0.81
Average True Range (ATR) 0.43 0.07
MACD 0.06 0.00
Stochastic Oscillator 51.82 40.04

Price Performance

Historical Comparison
CPIX
CYPH

About CPIX Cumberland Pharmaceuticals Inc.

Cumberland Pharmaceuticals Inc is a specialty pharmaceutical company focused on the acquisition, development, and commercialization of branded prescription pharmaceutical products. The Company has one operating segment which is specialty pharmaceutical products. The company's target markets are hospital acute care, gastroenterology, rheumatology, and oncology. The company promotes its approved products through its hospital, field, and oncology sales divisions in the United States and establishes a network of international partners to register and provide medicines to patients in their countries. The company's revenue is derived from the product sales of FDA-approved pharmaceutical brands. Its brands include Acetadote, Caldolor, Kristalose, Omeclamox, Sancuso, Vaprisol and Vibativ.

About CYPH Cypherpunk Technologies Inc.

Cypherpunk Technologies Inc is a privacy technology company focused on implementing a digital asset treasury business anchored by Zcash, which is a cryptographic digital asset that operates on a decentralized, open-source blockchain network known as the Zcash Network. Through its subsidiary, the company is also engaged in developing novel therapies for patients with cancer. The group holds Zcash as part of its digital treasury business and has the following drug candidates under development in its biopharma business: Sirexatamab (DKN-01), a monoclonal antibody that inhibits Dickkopf-related protein 1, or DKK1; and a preclinical antibody program, FL-501, that is designed to treat cachexia-related indications.

Share on Social Networks: